OpenVSafe by OpenVAERS
Search V-safe

8P5-22144-66273

2 vaccinations 9 coded responses 23 check-ins 9 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
958 / CA
Registered
2021-04-30
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-30
    Registered in v-safe
  2. 2021-04-30
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-30
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-05-01
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-05-02
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-05-03
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased, Blood pressure increased — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness
    Free text: Increased blood sugar, increased blood pressure
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-05-05
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased — Feeling: Fair · Headache, Fatigue or tiredness, Nausea
    Free text: Blood sugar spiking yesterday and today (forgot to report yesterday)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-05-06
    Survey response — days 1–6 daily, dose 1
    MedDRA: Blood glucose increased — Feeling: Fair · Fatigue or tiredness
    Free text: High blood sugar
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-05-07
    Health check-in — day 7, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  10. 2021-05-14
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-05-21
    Dose 2 — Pfizer-BioNTech
  12. 2021-05-21
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  13. 2021-05-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  14. 2021-05-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Good · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-05-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Free text: Swollen lymph node under arm
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-05-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Free text: Swollen lymph node in armpit (injection side)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-05-27
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Muscle or body aches, Fatigue or tiredness
    Free text: Swollen lymph node armpit
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-05-28
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-06-04
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-06-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-06-18
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-06-27
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-07-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-08-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-11-21
    Survey response — 6 months, dose 2
    MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional
    Free text: Symptoms: Episodes of nerve pain in leg and in hands have become more frequent and longer lasting since receiving the 2nd dose. · Healthcare visit (other): Primary Care Physician and specialist visits
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-11-21
    Report sent to call center — 6 months, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  27. 2021-11-24
  28. 2022-05-22
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-30Pfizer-BioNTech
22021-05-21Pfizer-BioNTech

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 8 — days 1–6 daily, dose 1

2021-05-02

Systemic reaction (other): Dizziness

2021-05-03

Systemic reaction (other): Increased blood sugar, increased blood pressure

2021-05-05

Systemic reaction (other): Blood sugar spiking yesterday and today (forgot to report yesterday)

2021-05-06

Systemic reaction (other): High blood sugar

Release 8 — days 1–6 daily, dose 2

2021-05-23

Systemic reaction (other): Dizziness

2021-05-25

Systemic reaction (other): Swollen lymph node under arm

2021-05-26

Systemic reaction (other): Swollen lymph node in armpit (injection side)

2021-05-27

Systemic reaction (other): Swollen lymph node armpit

Release 10 — 6 months, dose 2

2021-11-21

Symptoms: Episodes of nerve pain in leg and in hands have become more frequent and longer lasting since receiving the 2nd dose.
Healthcare visit (other): Primary Care Physician and specialist visits

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDCondition aggravated · · ✓
SDPre-existing disease · · ✓
SROBlood glucose increased ✓ ✓ ✓
SROBlood pressure increased ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release